SCHEMBL6538465

SCHEMBL6538465

CC(C)n1nc(-c2ccc(NCc3cccnc3)nc2-c2ccccc2)ccc1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.43
PDE9A O76083 1/20 0.43
CYP1A2 P05177 7/20 0.42
CYP3A4 P08684 7/20 0.42
CLK4 Q9HAZ1 6/20 0.42
CYP2D6 P10635 6/20 0.42
ALDH1A1 P00352 5/20 0.42
HSD17B10 Q99714 4/20 0.42
CYP2C19 P33261 6/20 0.41
ALOX15 P16050 2/20 0.41
USP2 O75604 1/20 0.41
MAPK1 P28482 2/20 0.40
KMT2A Q03164 3/20 0.40
HIF1A Q16665 1/20 0.40
GSK3B P49841 2/20 0.40
F2 P00734 1/20 0.39
KLKB1 P03952 1/20 0.39
APAF1 O14727 1/20 0.39
HK1 P19367 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6539007 0.91 PDE9A (0.39) PDE9ACYP1A2CYP3A4CLK4CYP2D6
SCHEMBL6538385 0.90 RET (0.41) PDE9ACYP1A2CYP3A4CLK4CYP2D6
SCHEMBL6539255 0.83 KDM4E (0.41) ALDH1A1HSD17B10ALOX15USP2KMT2A
SCHEMBL6538445 0.81 CSNK1D (0.47) ALDH1A1HSD17B10CYP2C19RAB9APOLB
SCHEMBL6134404 0.79 ADORA2A (0.45) GPR84PDE9ACYP1A2CYP3A4CLK4
SCHEMBL6538914 0.79 TP53 (0.38) HSD17B10POLBKDM4E
SCHEMBL6539021 0.76 TP53 (0.45) CYP3A4CLK4ALDH1A1POLBKDM4E
SCHEMBL6133144 0.75 RAB9A (0.48) ALDH1A1USP2MAPK1KMT2ARAB9A
SCHEMBL6538384 0.75 TP53 (0.44) KMT2ARAB9APOLBKDM4E
SCHEMBL6539065 0.74 ADORA1 (0.43) CYP1A2CYP3A4CYP2C19RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040067955-A1 Pyridazinone compound and pharmaceutical use thereof FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067955-A1 Pyridazinone compound and pharmaceutical use thereof ADORA1, ADORA2A, P2RX5 GPR84 2284/4885PDE9A 282/4885CYP1A2 772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.